Bio Preventive Medicine Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bio Preventive Medicine Corp

Watchlist Manager

Watchlist

Price: 19.8 TWD -4.12%

Market Cap: NT$979.1m

B	Bio Preventive Medicine Corp TPEX:6810	TW
	Neuropace Inc NASDAQ:NPCE	US
	Sea Ltd NYSE:SE	SG
C	Castellum Inc AMEX:CTM	US
	Khong Guan Ltd SGX:K03	SG

Profitability Summary

Bio Preventive Medicine Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

91%

Declining Gross Margin

90% > 88%

Negative Operating Margin

-3.241%

Negative 3Y Average Operating Margin

-3.035%

Operating Margin is Increasing

-3.734% > -3.241%

Negative Net Margin

-3.209%

Negative 3Y Average Net Margin

-3.050%

Net Margin is Increasing

-3.759% > -3.209%

Negative Free Cash Flow Margin

-3.131%

Negative 3Y Average Free Cash Flow Margin

-2.793%

Free Cash Flow Margin is Increasing

-8.911% > -3.131%

Negative ROE

-32%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-50%

Declining ROIC

-49% > -58%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.